EUVIMEDEUVIMED entdecken
Crossref

The metabolic effects of hormonal treatment in transgender males: Safety of the testosterone gender-affirming therapy

Charalampos Milionis, Ioannis Ilias, Evaggelia Venaki, Eftychia Koukkou

International Journal of Risk & Safety in Medicine · 13.01.2023 · 34 (1) · 21-28

DOI: 10.3233/jrs-200087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Risk & Safety in Medicine, erschienen am 13.01.2023. Verfasst von Charalampos Milionis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetes and Metabolism, General Hospital "Elena Venizelou", Athens, Greece. Hauptthemen laut MEDLINE: Transgender Persons, Transsexualism. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Gender dysphoria is characterised by a sense of distress because of discordance between the self-perception of gender identity and the assigned sex. Hormonal treatment of transgender males uses testosterone to induce and preserve masculinisation. OBJECTIVE: The study investigated the safety of testosterone therapy in transgender males. METHODS: The present study used a retrospective file review of transgender male subjects who were treated with testosterone (initially transdermal testosterone gel and subsequently parenteral testosterone undecanoate) for at least 18 months and had subsequently achieved a serum testosterone level within the normal range of cisgender male counterparts. Changes in somatometric data and blood biomarkers were investigated. RESULTS: The mean testosterone serum levels after approximately 18 months of treatment were about 545 ng/dL (SD ± 94 ng/dL). There was a statistically significant rise in body mass index (𝜒d = +1.23 kg/m2) with a reduction in blood glucose (𝜒d = −5.33 mg/dL) as well as statistically significant increases in aspartate transaminase (𝜒d = +4.3 U/L), haemoglobin (𝜒d = +1.72 g/dL), and haematocrit (𝜒d = +4.76%). In contrast, there were no significant changes in the lipidaemic profile of the subjects. CONCLUSIONS: Treatment with testosterone is routinely used for the promotion of virilising physical changes in transgender males. However, the likelihood of adverse effects of continuous treatment is still unclear. This study contributed to the notion that achieving testosterone levels within the target range is a prerequisite for the safety of the gender-affirming treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transgender PersonsTranssexualismHumansMaleFemaleGender IdentityRetrospective StudiesTestosterone

Stichwörter der Autor:innen

Transgender personsevidence-based medicinetestosterone

Substanzen

Testosterone

Autor:innen und Institutionen

  • Department of Endocrinology, Diabetes and Metabolism, General Hospital "Elena Venizelou", Athens, Greece.

Zitieren

APA

Milionis, C., Ilias, I., Venaki, E., & Koukkou, E. (2023). The metabolic effects of hormonal treatment in transgender males: Safety of the testosterone gender-affirming therapy. International Journal of Risk & Safety in Medicine, 34(1), 21-28. https://doi.org/10.3233/jrs-200087

Vancouver

Milionis C, Ilias I, Venaki E, Koukkou E. The metabolic effects of hormonal treatment in transgender males: Safety of the testosterone gender-affirming therapy. International Journal of Risk & Safety in Medicine. 2023;34(1):21-28. doi:10.3233/jrs-200087

BibTeX
@article{Milionis2023,
  author = {Milionis, Charalampos and Ilias, Ioannis and Venaki, Evaggelia and Koukkou, Eftychia},
  title = {The metabolic effects of hormonal treatment in transgender males: Safety of the testosterone gender-affirming therapy},
  journal = {International Journal of Risk & Safety in Medicine},
  year = {2023},
  volume = {34},
  number = {1},
  pages = {21--28},
  doi = {10.3233/jrs-200087}
}
Kostenlos starten →